PMID- 7978570 OWN - NLM STAT- MEDLINE DCOM- 19941201 LR - 20190717 IS - 0196-0644 (Print) IS - 0196-0644 (Linking) VI - 24 IP - 5 DP - 1994 Nov TI - Electroencephalographic mapping and 99mTc HMPAO single-photon emission computed tomography in carbon monoxide poisoning. PG - 947-52 AB - STUDY OBJECTIVE: To investigate whether topographic analysis of EEG mapping and technetium-99m (99mTc) hexamethylpropylenamine oxide (HMPAO) brain single-photon emission computed tomography (SPECT) can detect cerebral anomalies in the acute phase of carbon monoxide poisoning. DESIGN: Twelve patients aged 18 to 55 years with severe carbon monoxide poisoning and no history of neurologic disorder were evaluated. Either nasal (5 patients) or hyperbaric (7 patients) oxygen therapy was administered. Criteria for hyperbaric oxygen therapy were blood CO of more than 20%, loss of consciousness, pregnancy, or signs of cardiac injury. After oxygen treatment, all patients had a blood CO value of 0% and no patient had persistent acute signs of toxicity. Patients then were investigated by confentional EEG, EEG mapping, and 99mTc HMPAO brain SPECT. These procedures were performed on the day of admission. PARTICIPANTS: After nasal (5 patients) or hyperbaric (7 patients) oxygen therapy was administered, 12 adults with severe carbon monoxide poisoning were evaluated. All studies were performed on the day of admission. MEASUREMENTS: Conventional EEG, EEG mapping, and 99mTc HMPAO brain SPECT. RESULTS: While classic EEG was normal in 9 of 12 patients and showed diffuse anomalies in 3, EEG mapping and 99mTc HMPAO brain SPECT demonstrated unilateral or bilateral regional anomalies in 8 of 12 patients. Anomalies were localized in temporo-parieto-occipital areas, the watershed areas of the major cerebral arteries, or in temporal cortex. CONCLUSION: These preliminary results suggest that EEG mapping and 99mTc HMPAO brain SPECT can be complementary tools to diagnose early regional cerebral anomalies in carbon monoxide-poisoned patients. FAU - Denays, R AU - Denays R AD - Department of Neurology, St Pierre Hospital, Free University of Brussels, Belgium. FAU - Makhoul, E AU - Makhoul E FAU - Dachy, B AU - Dachy B FAU - Tondeur, M AU - Tondeur M FAU - Noel, P AU - Noel P FAU - Ham, H R AU - Ham HR FAU - Mols, P AU - Mols P LA - eng PT - Clinical Trial PT - Comparative Study PT - Journal Article PL - United States TA - Ann Emerg Med JT - Annals of emergency medicine JID - 8002646 RN - 0 (Organotechnetium Compounds) RN - 0 (Oximes) RN - 3B744AG22N (Technetium Tc 99m Exametazime) RN - 7U1EE4V452 (Carbon Monoxide) SB - IM MH - Acute Disease MH - Adolescent MH - Adult MH - Brain Diseases/chemically induced/*diagnosis/physiopathology MH - Brain Mapping/*methods MH - Carbon Monoxide/blood MH - Carbon Monoxide Poisoning/blood/*complications/therapy MH - Electroencephalography/*methods MH - Female MH - Humans MH - Hyperbaric Oxygenation MH - Male MH - Middle Aged MH - *Organotechnetium Compounds MH - *Oximes MH - Oxygen Inhalation Therapy MH - Sensitivity and Specificity MH - Severity of Illness Index MH - Technetium Tc 99m Exametazime MH - Tomography, Emission-Computed, Single-Photon/*methods EDAT- 1994/11/01 00:00 MHDA- 1994/11/01 00:01 CRDT- 1994/11/01 00:00 PHST- 1994/11/01 00:00 [pubmed] PHST- 1994/11/01 00:01 [medline] PHST- 1994/11/01 00:00 [entrez] AID - S019606449400212X [pii] AID - 10.1016/s0196-0644(94)70212-8 [doi] PST - ppublish SO - Ann Emerg Med. 1994 Nov;24(5):947-52. doi: 10.1016/s0196-0644(94)70212-8.